MLchartDataset catalogue

Genasense

Term · Oncology and biomedicine · MLC-T-ONC-003467

A substance being studied in the treatment of cancer. It may kill cancer cells by blocking the production of a protein that makes cancer cells live longer and by making them more sensitive to anticancer drugs. It is a type of antisense oligodeoxyribonucleotide. Also called augmerosen, bcl-2 antisense oligodeoxynucleotide G3139, and oblimersen sodium.

Table 1. Record
IdentifierMLC-T-ONC-003467
FieldOncology and biomedicine
Synonymsaugmerosen; bcl-2 antisense oligodeoxynucleotide G3139; oblimersen sodium
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003467",
  "term": "Genasense",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of cancer. It may kill cancer cells by blocking the production of a protein that makes cancer cells live longer and by making them more sensitive to anticancer drugs. It is a type of antisense oligodeoxyribonucleotide. Also called augmerosen, bcl-2 antisense oligodeoxynucleotide G3139, and oblimersen sodium.",
  "synonyms": [
    "augmerosen",
    "bcl-2 antisense oligodeoxynucleotide G3139",
    "oblimersen sodium"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/genasense/"
}

Record 7,885 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.